-+ 0.00%
-+ 0.00%
-+ 0.00%

Zhitong Finance App News, Shisi Pharmaceutical Group (02005.HK) announced that the Group's diltiazide hydrochloride tablets (30mg) have obtained approval from the China National Drug Administration to pass the consistent evaluation of generic drug quality and efficacy, making it the third domestic company to be approved. Diltiazam hydrochloride tablets are mainly used to treat angina pectoris and mild or moderate primary hypertension.

Zhitongcaijing·09/02/2026 09:09:07
Listen to the news
Zhitong Finance App News, Shisi Pharmaceutical Group (02005.HK) announced that the Group's diltiazide hydrochloride tablets (30mg) have obtained approval from the China National Drug Administration to pass the consistent evaluation of generic drug quality and efficacy, making it the third domestic company to be approved. Diltiazam hydrochloride tablets are mainly used to treat angina pectoris and mild or moderate primary hypertension.